SOPHiA GENETICS SA (NASDAQ:SOPH – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after BTIG Research raised their price target on the stock from $8.00 to $9.00. BTIG Research currently has a buy rating on the stock. SOPHiA GENETICS traded as high as $7.20 and last traded at $7.0120, with […]

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) reached a new 52-week high during trading on Monday after Royal Bank Of Canada raised their price target on the stock from $85.00 to $90.00. Royal Bank Of Canada currently has an outperform rating on the stock. DexCom traded as high as $84.82 and last traded at $84.82, […]

Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) shares reached a new 52-week high during trading on Tuesday after Wedbush raised their price target on the stock from $17.00 to $20.00. Wedbush currently has an outperform rating on the stock. Climb Bio traded as high as $14.42 and last traded at $12.79, with a volume […]

Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after Morgan Stanley raised their price target on the stock from $100.00 to $120.00. Morgan Stanley currently has an overweight rating on the stock. Arrowhead Pharmaceuticals traded as high as $88.11 and last traded at […]